Brief: Somalogic Reports Third Quarter 2021 Financial Results
15/11/2021 12:32
Nov 15 (Reuters) - Somalogic Inc SLGC.O :
* SOMALOGIC REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.55
* SEES FY REVENUE $77 MILLION TO $79 MILLION
* Q3 REVENUE ROSE 40 PERCENT TO $20 MILLION
Source text for Eikon: ID:nGNX84H8c0
Further company coverage: SLGC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders